X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$4.26
+4.16%
Mkt Cap $375.39M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+182.0%
Consensus $12.00 vs current $4.26
NASDAQ·Healthcare·Biotechnology
$4.26
+4.16%
Mkt Cap $375.39M
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
+182.0%
Consensus $12.00 vs current $4.26